Research Foundation for Mental Hygiene, Inc.
Psychiatric Institute Division
Last Update: 10/24/06
N A M E
S P O N S O R
T I T L E
A.ABI-DARGHAM
ELI LILLY
Dopamine D2 Receptors Occupancy with Olanzapine and Risperidone
A.ABI-DARGHAM
BRISTOL-MYERS
Occupancy of Striatal and Extrastriatal D2 Receptors Achieved by Therapeutic Doses of Aripiprazole in Patients with
A.ABI-DARGHAM
OTSUKA AMERICA
Training Program
A.ALBANO
DUKE UNIV
Substance Use Outcomes Following Treatment for Adolescent Depression (SOFTAD)
A.ALBANO
MH064092-05
Child/Adolescent Anxiety Multimodal Treatment Study (CAMS)
A.ALBANO
DUKE UNIV
Substance Use Outcomes Following Treatment for Adolescent Depression (SOFTAD)
H.ANDREWS
AG16381-05
Multicenter Vitamin E Trial in Persons with Down Syndrome
H.ANDREWS
COLUMBIA UNIV
Consortium w/Columbia: Cooperative Multicenter Traumatic Brain Injury Clinical Trials Network
H.ANDREWS
MT. SINAI
Subcontract w/Mt. Sinai School of Medicine: Alzheimer's Disease Prevention Trial with Estrogens
H.ANDREWS
COLUMBIA UNIV
Subcontract w/Columbia University: Epidemiology of Dementia in an Urban Community
H.ANDREWS
COLUMBIA UNIV
Subcontract with Columbia University: NIH/NIA P50 AG08702 Alzheimer's Disease Research Center @ Columbia Univ.
H.ANDREWS
COLUMBIA UNIV
Subcontract w/Columbia Univ.: Columbia Center for Homelessness Prevention Studies
G.ANSORGE
NARSAD
Consequences of SERT Inhibition during Development on Adult Behavior and Neurophysiology
V.ARANGO
MH40210-21
Postmortem Neurochemical Studies in Suicide
V.ARANGO
AFSP
The Role of Ventral Striatal Cannabinoidergic Signaling in the Neurobiology of Suicide
E.ATTIA
MH069868-03
Atypical Antipsychotic Medication in Anorexia Nervosa
E.ATTIA
MH070597-02
Anorexia Nervosa: The Importance of Treatment Intensity
E.ATTIA
PRESBYTERIAN
Subcontract w/Presbyterian Hospital: Comprehensive Care Center for Eating Disorders
G.BARR
DA06600-15
Opiate Withdrawal and Tolerance: Development and Plasticity
G.BARR
NS047159-03
Ontogenic Changes in Injury-Induced Gene Expression
G.BARR
NYS SPINAL CORD
Gene Expression After Acute and Chronic Injury and Rescue
G.BARR
NS054183-01A1
Amygdala Gene Expression: Learning in a Sensitive Period
S.BARROW
CORP SUPP HOUSING
Evaluation of the Closer to Home Initiative
A.BESELMAN
AG016381-05
Vitamin E Pharmacy
A.BISAGA
DA017572-04
Developing Medication for Tobacco Addiction: NMDA Agents
A.BISAGA
DA015822-02
Memantine Naltrexone Treatment for Opioid Dependence
C.BLANCO
DA019606-01A2
Substance Abuse in U.S. Hispanics: A National Study
C.BLANCO
DA020783-01A1
SMART: Improving Detection & Outcome of Psychiatric Comorbidity in Drug Treatment
C.BLANCO
OASAS
Gambling Prevention Program
C.BLANCO
OASAS
Gambling Treatment Program
A.BROWN
MH073080-01A1
Prenatal Factors and Risk of Bipolar Disorder
G.BRUDER
MH36295-22
Behavioral, ERP and EEG Asymmetry in Affective Disorders
G.BRUDER
MH066597-03
Subtypes of Schizophrenia: ERPs During Memory Processing
K.BRUNELLI
NARSAD
Gene Expression and QTL Mapping in Rats Selectively Bred for Infant Anxiety
S.BRUNELLI
PREDIX PHARMA
Testing Anxiolytic Compounds in Ultrasonic Vocalizations of Infant Rats
A.CARBALLO
MH069333-03
Internet Use and HIV Risk among Men in NYC
A.CARBALLO
HD046060-04
Topical Microbicide Acceptability
A.CARBALLO
MH073410-02
Predictors of HIV Risk Behavior Among Men in Argentina
P.COHEN
DUKE UNIVERSITY
Subcontract w/Duke University: Multi-Site Longitudinal Analysis of Psychiatric Risk for SUDs
P.COHEN
MH60911-06
Personality Disorder Over 20 Years: Risks, Course & Impact
S.COMER
DA016759-04
Prescription Opioid Effects in Drug and Non-drug Abusers
S.COMER
DA022222-01
Sustained-release Naltrexone for Opioid Dependence: Longitudinal Study in Humans
S.COMER
GRUNENTHAL GMBH
Relationship Between Infusion Duration and Reinforcing Efects of Intravenous Oxycodone in Heroin-Dependent Individu
J.COPLAN
SMITHKLINE BEECH
Neuroimaging Studies in Generalized Anxiety Disorder During Treatment with Paroxetine
J.COPLAN
FOREST LABORATORY
Citalopram Treatment for Irritable Bowel Syndrome (IBS) Comorbid with Anxiety Disorders
L.COVEY
DA13035-05
Supplement: CU Partners: NY/Long Island Regional Node
D.DEVANAND
UNIV OF NC
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
D.DEVANAND
AG021488-04
Antipsychotic Discontinuation in Alzheimer's Disease
D.DEVANAND
ELI LILLY
Open-Label Duloxetine Treatment Trial of Dysthymic Disorder in the Elderly
K.DUFF
NS048447-02
Pathological and Functional Impact of Tauopathy in Vivo
K.DUFF
ASTRAZENECA AB
In Vivo Efficacy Studies with the Compounds AR1 and AR2
A.DWORK
MH64168-05
Golgi Studies of Schizophrenia
L.E-BENCHEKROU
AFSP
Gene Expression Changes in the Dorsal Raphe Nucleus of Suicides
L.E-BENCHEKROU
AFSP
Mentor (Underwood)Gene Expression Changes in the Dorsal Raphe Nucleus of Suicide
L.E-KIMLING
MH019560-33
A Prospective Study of Children of Schizophrenic Parents
A.EHRHARDT
MH43520-18
HIV Center for Clinical and Behavioral Studies
A.EHRHARDT
263-MI-605318
Understanding the Social and Psychological Context of Acute HIV Infection
J.ENDICOTT
PFIZER
Pfizer Review
J.ENDICOTT
PFIZER
SADS-C (Modified for Bipolar Disorders)
J.ENDICOTT
MERCK RES LAB
Double-Blind, Multicenter, Placebo & Active-Controlled Acute & Extension Study of MK-0869 in Treatment of Patients
J.ENDICOTT
PFIZER
Psychometric Assessment of the Reliability and Validity of Two Outcome Measures For Use In A Chronic Spinal Cord In
J.ENDICOTT
MERCK
Mini and Hama Review of a Double-Blind, Multi-ctr, Placebo-Controlled Replicate Study of L-830982 GEM 3 mg B.I.D. t
J.ENDICOTT
MH23864-33
Collaborative Depression Study
J.ENDICOTT
CYBERONICS
Collection of Therapeutic Outcomes
S.EVANS
DA12675-05
Cocaine's Effects Across the Menstrual Cycle
S.EVANS
DA016762-03
Effects of Smoked Heroin Across the Menstrual Cycle
S.EVANS
DA009114-11A1
Vulnerbility to Anxiolytic Abuse in Women
T.EXNER
AMBASE FDN
Promotion of Dual Protection
T.EXNER
MH074370-02
A Structural Intervention to Enhance Female Condom Use
B.FALLON
LYME RESEARCH FDN
Neurobiological and Neuropsychological Studies of Late Lyme Disease
B.FALLON
SOLVAY
Fluvoxamine in Hypochondriasis
B.FALLON
LYME DISEASE ASSO
Neurobiological and Neuropsychological Studies of Late Lyme Disease
B.FALLON
MH071456-01A2
Treatment of Hypochondriasis with CBT &/or SSRI
V.FERRERA
MH59244-08
Attention and Voluntary Action in Prefrontal Cortex
E.FERTUCK
APA
Conscious and Unconscious Processing of Social Stimuli in Borderline Personality
W.FIFER
MH058769-08
Meeting of the International Society for Developmental Psychobiology
W.FIFER
HD32774-10A1
Perinatal Assessment of At-Risk Populations
P.FISHER
MH078575-01
Computerized Screen for Adverse Events Associated with SSRI's in Youth
R.FOLTIN
DA04130-18
Anorectic Drugs: Abuse & Behavioral Mechanisms of Action
R.FOLTIN
DA008105-13
Laboratory Analysis of Cocaine Abstinence
W.FRANKLE
GLAXOSMITHKLINE
Examination of Antipsychotic Limbic Selectivity in Preclinical Studies
W.FRANKLE
PFIZER
Occupancy of Striatal and Extrastriatal D2 Receptors Acheived by High Dose Oral Ziprasidone vs. Conventional Dosing
D.FRIEDMAN
AG09988-12
Age-Related ERP Measures in Alzheimer's Disease
D.FRIEDMAN
AG05213-19
Effects of Age on the Cognitive ERPD/Cardiac Waveffect
D.FRIEDMAN
HD14959-20
Maturation of Cognitive-Related Brain Potentials
A.FYER
NARSAD
An Insolate Population for Genetic Study of Panic Disorder
R.GIL
BRISTOL-MYERS
A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Three Fixed Doses of Aripiprazole in the Treat
R.GIL
GENERAL HOSPITAL
Subcontract w/General Hospital Corp: High Dose Ziprasidone Versus Conventional Dosing in Schizophrenia Patients wit
J.GINGRICH
MH076026-01
Gene-Environment Interactions and Vulnerability to Neuropsychiatric Disorders
J.GINGRICH
MH073794-02
Epigenetic Mechanisms: Paternal Age and Neural Function
A.GLASSMAN
PFIZER
A 7-Wk Double-blind, Placebo-controlled,Randomized,Multicenter Study Evaluating the Safety & Efficacy of 3 Doses of
M.GOLDBERG
EY014978-04
The Neurophysiology of Spatial Vision
H.GORDON
NARSAD
Neurophysiological Correlates of Hippocampal Serotonon-1A Receptor Function
J.GOTTLIEB
EY014697-04
Parietal Mechanisms of Vision and Attention
M.GOULD
CE000258-02
Help Seeking by At-Risk Youth After Suicide Screenings
M.GOULD
MHA OF NYC
Subcontract w/Mental Health Assoc of NYC: Evaluation of Networking Suicide Prevention Hotlines
M.GOULD
AFSP
Teenage Bullying as a Risk for Later Depression and Suicidality
M.GOULD
FDA
Sudden Death and Use of Stimulant Medications in Youth
L.GREENHILL
MH12007
Follow-up of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (MTA)
L.GREENHILL
MH066762-05
RUPP-PI in New York City
L.GREENHILL
KAI, INC.
Clinical Coordination and Data Management Center
L.GREENHILL
UCI R&GS RESEARCH
Subcontract with UCI R&GS Research: Molecular Genetics of ADHD in the MTA Sample / NINDS
L.GREENHILL
MH060903-06
Follow-up of the PATS Sample
L.GREENHILL
NOVARTIS PHARMA
Double-blind Study of Focalin XR in Children with ADHD
L.GREENHILL
BRISTOL MYERS
Developing More Efficacious Treatments for Children with ADHD Who are "Partial" or "Non-responders" to Stimulants
L.GREENHILL
FOREST RESEARCH
Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients with Major Depressive Disorder
L.GUO
NARSAD
Development and Validation of a New Imaging Method to Probe Cortico-Striatal Glutamatergic Function with PET
M.HANEY
DA019239-03
Medication Development for Marijuana Relapse
C.HART
DA003476-21
Drug Effects on Behavior: Workplace Implications e
C.HART
SAM TECHNOLOGY
Drug Effects on Behavior: Workplace Implications
C.HART
DA019559-02
Intranasal Methamphetamine: A Pharmacotherapy Model
D.HASIN
AA013654-04
Alcohol in Israel: Genetic and Environmental Effects
D.HASIN
DA018652-03
Phenotypes for Drug Abuse: Epidemiologic-Genetic Approach
D.HASIN
AA014323-02
Reducing Unsafe Drinking in HIV Primary Care
R.HAWKINS
NS045108-04
Aggregation of Presynaptic Proteins During LTP
D.HELLERSTEIN
LILLY RESEARCH
Functional and Anatomical MRI Changes After Treatment of Chronic Depression with Duloxetine
R.HEN
CORNELL UNIV.
Subcontract w/Cornell Univ: Hallucinogens and 5-HTZA Receptors
R.HEN
UNIV OF PENN
Subcontract w/Univ of Penn: Biology of Serotonin in the Brain; Project II: 5-HT1A Receptors During Development and
R.HEN
MH068542-04
Cellular Mechanisms of Antidepressant Action
D.HERMAN
MH59716-05
CTI in the Transition from Hospital to Community
K.HOAGWOOD
MH071745-02
Service Effectiveness Pilot Study of Parent Empowerment
K.HOAGWOOD
COORDINATED CARE
Parent Empowerment Program - State Initiative
K.HOAGWOOD
MH074774-02
Readiness to Adopt EBPs in Schools
K.HOAGWOOD
MH078178-01
Developing Center: Implementing Evidence-Based Practices for Children
S.HOFFMAN
COMM HEALTHCARE
Subcontract w/Community Healthcare Network, Inc.: Development & Evaluation of Peer Support for Brooklyn-based HIV+
C.HOVEN
AMERICAN RED CROS
Identifying and Treating Children of 9/11 EMTs and Those Attending WTC Exposed Catholic High Schools
C.HOVEN
HD046786-01A2
Violence and Mental Health: Children of First Responders
C.HOVEN
WESTCHEST JEWISH
Subcontract with Westchester Jewish Community Svces: Linkages II Evaluation
C.HOVEN
NYCDMH
Consortium w/ NYCDMH: Keeping Families Together
C.HOVEN
NYC DEPT OF ED
Subcontract w/NYC Department of Education: Safe and Drug Free Schools Project
J.JAVITCH
WEILL MED COLL
Subcontract w/Weill Med Coll of Cornell Univ: Opioid Receptor Oligomerization: Prediction and Validation
J.JAVITCH
WEILL MED COLLEGE
Subcontract w/Weill Medical College of Cornell Univ: Structure and Function of the Dopamine Transporter
J.JAVITCH
VANDERBILT UNIV
Subcontract w/Vanderbilt Univ Med Ctr: Amphetamine Regulation of Dopamine Transport
J.JAVITCH
DA011495-09
Dopamine Transporter: Substrate and Cocaine Binding Sites
J.JAVITCH
MH054137-12
Structure of the Dopamine D2-Like Receptor Binding Sites
P.JENSEN
COORDINATED CARE
School Based Mental Health Project Scope of Services
P.JENSEN
MH067100-04
A Theory-Based Intervention to Change Physician Behavior
P.JENSEN
CASEY FOSTER CARE
Casey Foster Care Program
J.KEILP
NARSAD
Neuropsychological Characteristics of Suicide
J.KEILP
NARSAD
Localization of Selective Attention Deficits in High Lethality Suicide Attempters
H.KLEBER
TAP PHARM
Safety, Psychological Effects and Behavioral Effects of A-77000
H.KLEBER
DA09236-13
Novel Medication Approaches for Substance Abuse
D.KLEIN
MH067749-02
Psychobiology of IV Naloxone & Lactate in Normals
R.KLITZMAN
HG02431-04
Views of Privacy of Genetic Information
R.KLITZMAN
HG004214-01
Views and Approaches Toward Research Integrity Among IRBs
L.KOTLER
NEDA
A Comparison of Cognitive-Behavioral Psychotherapy and Supportive Psychotherapy in Adolescents with Bulimia Nervosa
G.L-FERNANDEZ
NARSAD
Assessing Psychosis Screeners Among Underserved Urban Primary Care Patients
R.L-FERNANDEZ
PFIZER
Training and Consultation-Liaison Program Between Academic Psychiatrists and Community Based PMD's
R.L-FERNANDEZ
MH073087-02
Culturally Congruent Program of MDD Care for Hispanics
R.L-FERNANDEZ
AMERICAN RED CROS
Collaborative Disaster Project in Washington Heights
M.LARUELLE
MH54192-10
Imaging of Dopamine Function in Schizophrenia
M.LARUELLE
GLAXOSMITHKLINE
PET Study to Evaluate Paroxetine Occupancy of the Serotonin Transporter (SERT) Using 11 [C]-DASB
C.LEU
ALBERT EINSTEIN
Subcontract w/Albert Einstein College of Medicine: Adolescent Relationships and HIV/STD Risk
C.LEU
ALBERT EINSTEIN
Subcontract with Albert Einstein College of Medicine: Reducing Risk Among Highly Vulnerable Youth
F.LEVIN
DA15451-04
Marijuana Dependence & Depression: Venlafaxine Treatment
F.LEVIN
DA019233-01
Atomoxetine for Marijuana-Abusing ADHD Adolescents
F.LEVIN
DA022217-01
Combined Pharmacotherapies for Cocaine Dependence
J.LIEBERMAN
MH066171-03
Neurobiology of Dopamine in Schizophrenia
J.LIEBERMAN
MH076544-01
Pharmacologic and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders
J.LIEBERMAN
VARIOUS CONSULTS
Consulting Services Agreement
J.LIEBERMAN
UNC-CH
Subcontract w/University of North Carolina-Chapel Hill: Clinical Antipsychotic Trials of Intervention Effectiveness
J.LIEBERMAN
ACADIA PHARMACEU
Escalating Dose Safety and Tolerability Study of ACP-104 in Schizophrenia
J.LIEBERMAN
JANSSEN
A 2-Year Prospective Blinded-rater Open-label Active-controlled Multicenter Randomized Study of Long-term Efficacy
J.LIEBERMAN
UNIV OF CALIFORNI
Subcontract w/University of California: Treatment Units for Research on Neurocognition and Schizophrenia (TURNS)
M.LIEBOWITZ
MH064726-04
CBT Augmentation of Paroxetine for Social Anxiety
M.LIEBOWITZ
GLAXOSMITHKLINE
CBT Augmentation of Paroxetine for Social Anxiety Disorder
S.LISANBY
NEURONETICS, INC.
Neuronetics rTMS for the Treatment of Depression
S.LISANBY
MH060884-07
Magnetic Stimulation Therapy: A New Convulsive Treatment
S.LISANBY
MH069895-03
Optimization of TMS for Depression
S.LISANBY
STANLEY MEDICAL
Magnetic Seizure Therapy (MST) for the Treatment of Severe Mood Disorder
S.LISANBY
CYBERONICS
Cyberonics Treatment Resistant Depression Registry
Y.LIU
AFSP
Serotonin Transporter Binding in the Amygdala of Depressed Suicide Victims
H.M-BAHLBURG
MT SINAI
Subcontract w/Weill Medical College: The Natural History of Rare Genetic Steroid Disorders
L.MAAYAN
ELI LILLY
Maintenance of Benefit After 8-Week and 52-Week Treatment with Atomoxetine Hydrochloride in Adolescents with Attent
L.MAAYAN
LILLY RESEARCH
Pharmacological Treatment of ADHD in Young Children
M.MACCHI
NS045086-02
Sleep and Circadian Rhythms After Pineal Resection
C.MALAPANI
BARNARD COLLEGE
Subcontract w/Barnard College: Time and Associative Learning
D.MALASPINA
MH59114-05
Jerusalem Perinatal Cohort Schizophrenia Study
D.MALASPINA
MH066428-03
Olfactory and Social Function in Schizophrenia
D.MALASPINA
VARIOUS RES SUPP
Elenka Family Gift for Schizophrenia and Other Psychiatric Disorders in Jerusalem
D.MANCEVSKI
NARSAD
A Naturalistic Study of Duration of Untreated Psychosis and Neuroleptic Response in Schizophrenia
J.MANN
MH56390-10
Familial Pathways to Early-Onset Suicide Attempts
J.MANN
MH62185-07
Conte Centers for the Neuroscience of Mental Disorders (CCNMD): The Neurobiology of Suicidal Behavior
J.MANTELL
HD046351-03
Female Condom Use in South African College Students
J.MARKOWITZ
NARSAD
Interpersonal Psychotherapy for Borderline Personality Disorder
R.MARSHALL
BRISTOL-MYERS
Placebo Controlled Trial of Nefazadore in Alcohol Dependent Individuals with Posttraumatic Stress Disorder
R.MARSHALL
MH068173-03
Combination Treatment for PTSD After the WTC Attack
J.MARTIN
CRPF
Engineering Spinal Connections to Bypass Spinal Injury
J.MARTIN
CRPF
Electrical Stimulation of the Corticospinal Tract after Incomplete Spinal Cord Injury
J.MARTIN
CRPF
Electrical Stimulation of the Corticospinal Tract after Incomplete Spinal Cord Injury
J.MARTIN
COLUMBIA UNIV
Subcontract with Columbia Univ: Activity Refines Corticospinal Terminations
D.MARTINEZ
DA16183-05
Kappa Receptor Selective PET Ligands
D.MARTINEZ
DA016788-02
PET Imaging of Mesolimbic Dopamine in Heroin Dependence
D.MARTINEZ
DA020855-02
Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
L.MAYER
DK066033-02
Does Metabolic Syndrome Exist in Anorexia Nervosa?
P.MCGRATH
AA13303-04
Alcohol Use Disorder in Patients Treated for Depression
C.MELLINS
MH069133-03
Mental Health and Risk in HIV+ Youth and Seroreverters
C.MELLINS
MT. SINAI
Subcontract with Mt. Sinai: CHAMP+: Supporting HIV-Infected Youth and Their Families
J.MORGENSTERN
DA015971-06
Club Drug Use and Risky Behaviors Among Men
J.MORGENSTERN
AA015553-01A1
Naltrexone and CBT for Problem Drinking MSM
L.MUFSON
COLUMBIA UNIV
Subcontract w/Columbia University: Group IPT-A in School-Based Clinics, 1R01 MH073640-01
M.MYERS
ES11596-05
Fetal Origins of Disease: Markers, Modulators, Mechanisms
Y.NERIA
GIFT ACCOUNT
Center for the Study of Trauma and Resilience Gift Account
Y.NERIA
MH072833-02
Long-Term Impact of WTC Attacks in Primary Care
E.NUNES
PFIZER
Study with Pathological Gamblers
E.NUNES
DA13035-05
CU Partners: NY/Long Island Regional Node
E.NUNES
DA016950-04
MI Training: Live Supervision by Tele-Conference
E.NUNES
DA10746-09A1
Opiate Dependence: Combined Naltrexone/Behavior Therapy
M.OLFSON
BRISTOL MYERS
Sexual Dysfunction and Use of Antipsychotic Medications
M.OLFSON
AFSP
Suicide Prevention through Treatment of Depression
M.OLFSON
BRISTOL MYERS
Antipsychotic Associated Hyperlipidemia
M.OLFSON
NARSAD
SSRI Treatment and Suicide in Depressed Youth
M.OQUENDO
MH59710-05
Pharmacotherapy of High-Risk Bipolar Disorder
L.PAPP
FOREST LABS
Escitalopram for the Treatment of Patients with Panic Disorder and Comorbid Asthma
L.PAPP
CEPHALON
A 12-Wk Open-Label followed by a 24-Wk Double-Blind Discontinuation Exploratory Study to Evaluate the Effects of GA
L.PAPP
MERCK
A Double-Blind, Multicenter, Placebo-Controlled Study of L-830982 Gel Extrusion Module (GEM) in Treatment of Outpat
L.PAPP
UCB PHARMA, INC.
Keppra (levetiracetam) and Co2 Induced Anxiety in Patients with Panic Disorder
E.PAPPADOPULOS
MH078700-01
ADHD Medication Adherence: A Parent-Provider Intervention Modeled from HIV
V.PATEL
MH065851-03
Cognitive Models of HIV Decision Making in Young Adults
G.PELTON
JEWISH COMMUNAL
Effects of Peripheral Immune Stimulation on Brain Activity
B.PETERSON
DA017820-03
MRI of Infants Exposed Prenatally to Drugs of Abuse
B.PETERSON
MH068318-03
Neuroanatomical MRI Studies of Childhood Disorders
E.PETKOVA
WRIGHT STATE
Subcontract with Wright State Univ.: Identification of Placebo Responders in Drug Treated Subjectss
H.PINCUS
ATLANTIC PHILANTR
Developing a Clinical Geriatric Policy Scholars Program
K.POSNER
SHIRE
...Crossover Study Designed to Assess the Time Course of Treatment Effect Tolerability & Safety of Methylphenidate
K.POSNER
SHIRE
A Phase III Multi-center, Open-label Study of Methylphenidate Transdermal System (MTS) in Pediatric Patients aged 6
K.POSNER
SUICIDE CENTER
Suicidality Classification Center - GSK
D.PRINTZ
PFIZER
52-Week Open Extension Study Evaluating the Safety and Efficacy of Continued Administration of 40-160mg Daily of Or
N.QIAN
EY016270-11A2
Computation and Psychophysics of Motion and Stereopsis
J.RABKIN
ALZA CORPORATION
A Randomized Controlled Trial of the Effect of Testosterone Replacement Testoderm..) Upon Body Composition in Hypog
J.RABKIN
PFIZER
Diagnosis and Treatment of Depression in patients with ALS
J.RABKIN
MH072383-02
Modafinil Treatment for Fatigue in HIV+ Patients
W.RABY
BRISTOL-MYERS
Evaluation of the Anxiolytic Effect of Serzone in Patients Suffering from Schizophrenia or Schisoaffective Disorder
S.RAYPORT
DA017978-02
Transgenic Analysis of Glutamate in Sensitization
R.REMIEN
COLUMBIA UNIV
Subcontract w/CU: STD/HIV Risk Reduction for African American Couples
R.REMIEN
COLUMBIA UNIV
Subcontract w/Columbia Univ: HIV/STI Prevention for Drug-Involved Couples
L.ROLE
PHILIP MORRIS
Susceptibility to Nicotine Dependence Due to Altered Expression of Neuregulin 1
L.ROLE
NS022061-21
Modulation of Neuronal Acetylcholine Receptors
L.ROLE
DA019941-02
In Vivo Studies of Neuregulin 1 in Addiction Pathways
S.ROOSE
SMITHKLINE BEECH
Paroxetine in Depressed Patients with Ischemic Heart Disease - A Multicenter Randomized Safety Study
S.ROOSE
LILLY RESEARCH
Open-Label Treatment with Duloxetine Hydrochloride Once-Daily dosing for Evaluation of Stabilization Dose in Patien
S.ROOSE
BRISTOL-MYERS
Aripiprazole Augmentation of Antidepressant Treatment
S.ROOSE
FOREST RESEARCH
Effects of Memantine (Namenda) in Elderly Depressed Patients with Cognitive Impairment Treated with Escitalopram (L
H.SACKEIM
CYBERONICS
Cyberonics - HRSD Training
H.SACKEIM
MH61609-05
Optimization of Electroconvulsive Therapy
H.SACKEIM
MH63435-04
Neuroimaging Correlates of ECT Outcomes
H.SACKEIM
MH35636-24
Affective and Cognitive Consequences of ECT
A.SAHAY
NARSAD
Molecular Mechanisms Underlying the Sensitive Period of Anxiety
S.SCHACHER
MH60387-05
Mechanisms Mediating Long-Term Synaptic Plasticity
D.SCHECHTER
IPA
Brain Activity of Traumatized Mothers in Response to Their Young Child's Distress: Neurobiological Correlates of Po
C.SCHMAUSS
MH56123-10
D3 Pre-mRNA Processing in Chronic Psychosis
F.SCHNEIER
FOREST LAB
Escitalopram Treatment of Major Depression and Comorbid Social Anxiety Disorder
F.SCHNEIER
UCB PHARMA
Levetiracetam vs. Placebo for Social Anxiety Disorder
S.SEIDMAN
PFIZER
A Parallel Group, Multicenter Flexible Dose Study with a Double-Blind Randomized Placebo-Controlled Phase and an Op
D.SHAFFER
AMERICAN MH FUND
Studies in Adolescent Suicide
D.SHAFFER
MH071478-03
ACISR for Pediatric Psychiatry Disorders
D.SHAFFER
CHARITABLE GIFT
Charitable Gift to the Department
H.SHAIR
MH077863-01
Formation of Infant/Father Social Relationships: Mechanisms and Modulators
L.SHER
AFSP
The Hypothalamic-Pituitary-Adrenal System in Suicide Attempters
L.SHER
AFSP
The Effects of Acute Tryptophan Depletion on Impulsivity in Suicide Attempters and Non-Attempters with Alcohol Depe
L.SHER
AFSP
Mentor Account: The Effects of Acute Tryptophan Depletion on Impulsivity in Suic and Non-Attempters with Alcohol De
H.SIMPSON
MH071570-01A2
Enhancing CBT Adherence in OCD with MI
H.SIMPSON
MH045436-13A1
Maximizing Treatment Outcome in OCD
A.SKODOL
MH50839-11
Collaborative Longitudinal Study of Personality Disorders
M.SLIFSTEIN
GLAXOSMITHKLINE
Characterization of New Pharmacological Compounds using PET
M.SPINELLI
PHERIN PHARM
A Phase 2 Study of the Use of PH80 for Management of the Symptoms of Clinically Significant Premenstrual Syndrome (
M.SPINELLI
MH069915-02
Antepartum Interpersonal Psychotherapy at 3 NYC Sites
B.STANLEY
MH61017-05
Treating Suicidal Behavior and Self-Mutilation in BPD
B.STANLEY
MH62665-05
Prospective Study of Suicidal Behavior in BPD
B.STANLEY
AA15630-03
DCIPS: Intervention with High Suicide Risk Individuals
B.STANLEY
MD516398
Professional Services Contract
J.STEWART
ORGANON PHARM
Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy & Safety of Org 330
J.STEWART
GLAXOSMITH-KLINE
Lamotrigine as an Antidepressant Augmentation Agent in Treatment Refractory Unipolar Depression
J.STEWART
ELI LILLY
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depressives (F1J-US-X006)
E.STRUENING
88 MO76567101
Secondary Analysis of Data From a NYSPI Epidemilogic Survey of Homeless ...
E.STRUENING
NYC #07206
CSS-Case Management Study: A Plus West 168th Street
E.STRUENING
NYC #07206
CSS-Shelter and Survey 93 Worth Street
E.STRUENING
NYC #04206
CSS-Shelter and Survey-93 Worth Street
M.SULLIVAN
DA020448-02
Predictors of Relapse to Prescription Opioid Abuse Among Pain Patients
E.SUSSER
KAISER FOUNDATION
Subcontract with Kaiser Foundation Research Institute: Prenatal Determinants of Schizophrenia II
M.TERMAN
GLAXOSMITHKLINE
7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/day of Extended-Release B
M.TERMAN
SLEEP RES SOCIETY
Melatonin Pharmacokinetics in Primary Insomniacs
H.THORNING
SEPT 11TH FUND
HOPE-NY: Healthy Outreach Through Psychoeducation
M.UNDERWOOD
AA011293-08
Dorsal Raphe Nucleus Serotonergic Neurons in Alcoholism
M.UNDERWOOD
AFSP
Serotonin and Norepinephrine Imbalance in Bipolar Disorder with Suicide
H.VERDELI
SOL GOLDMAN
Interpersonal Psychotherapy (IPT) for Adolescent Children of Bipolar Mothers: A Randomized Clinical Trial
M.WAINBERG
MH65163-05A1
RCT of a Brazilian HIV Prevention Intervention for the SMI
B.WALSH
MH65024-05
Translational Research on Eating Disorders
B.WALSH
ORTHO-MCNEIL
Multicenter Randomized Double-Blind Placebo-Controlled Flexible-Dose Study to Assess the Safety & Efficacy of Topir
B.WALSH
GLAXOSMITHKLINE
Eating Disorders Review
B.WASLICK
DUKE UNIV
Treatment of Adolescent Depression Study
G.WASSERMAN
SM57433-02
New York State Youth Suicide Prevention & Early Intervention
R.WATERHOUSE
MEDTRONIC SOFAMOR
Consulting Agreement
R.WATERHOUSE
ORGANON
Developing Imaging Paradigms for Assessing the In Vivo Effects of GlyT1 Modulation
M.WEISSMAN
UPJOHN
Sleep Disturbances and Cross National Studies
M.WEISSMAN
VARIOUS
Treatment of Depressed Parents and Offspring
M.WEISSMAN
NARSAD
Three Generations at Risk for Depression: Genetic Studies
M.WEISSMAN
GLAXOSMITHKLINE
Course of Major Depressive Disorder in a Low Income Primary Care Practice
M.WEISSMAN
MH60912-06
Genetics of Early-Onset Major Depression
A.WHITAKER
OC FOUNDATION
The Identification of Children with PANDAS by Immunological and Genetic Markers
A.WHITAKER
UNIV OF PENN
Subcontract w/Univ of Pennsylvania: The Epidemiology of Autism in a Low Birthweight Cohort
A.WHITAKER
CURE AUTISM NOW
The Effectiveness of A Light On Literacy for Autism: A Case Control Study
C.WIEDENMAYER
MH073994-01A1
Fear Memory Formation in Early Life
C.WIEDENMAYER
MH071751-01A2
The Prefrontal Cortex: Responses to Threat in Early Life
P.WU
DA017776-02
Adolescent Use of Substance Use Treatment Services
J.ZHAO
MH074008-01A1
Synthesis and Evaluation of Novel PET NET Tracers
J.ZHAO
SNM
Development of NMDA/Glycine Site PET Radioligands